Novavax (NVAX) closed at $7.91 in the latest ... On the other hand, the Dow registered a gain of 0.92%, and the technology-centric Nasdaq increased by 1.41%. Shares of the vaccine maker have ...

Novavax (NVAX) has been one of the most searched-for stocks on Zacks.com lately. So, you might want to look at some of the facts that could shape the stock's performance in the near term.

Bank of New York Mellon Corp lifted its stake in shares of Novavax, Inc. (NASDAQ:NVAX – Free Report) by 0.4% during the ...

Wealthfront Advisers LLC purchased a new position in shares of Novavax, Inc. (NASDAQ:NVAX – Free Report) in the fourth quarter, according to the company in its most recent disclosure with the SEC.

Shares of Novavax Inc. NVAX slipped 1.55% to $7.60 Friday, on what proved to be an all-around great trading session for the stock market, with the NASDAQ Composite Index COMP rising 0.52% to 17,784.05 ...

In the closing of the recent trading day, Novavax (NVAX) stood at $7.91, denoting a -0.57% change from the preceding trading day.

Shares of Novavax Inc. NVAX shed 5.13% to $7.95 Tuesday, on what proved to be an all-around poor trading session for the ...

Novavax Inc. closed 64.88% below its 52-week high of $23.86, which the company reached on June 6th.

With that in mind, let's consider two companies near their 52-week lows that still don't look attractive: Tilray Brands (NASDAQ: TLRY) and Novavax (NASDAQ: NVAX). Tilray Brands is a leader in the ...

The White House is reportedly considering former U.S. Rep. Michael Burgess (R-Texas) as its nominee to head the CDC. Burgess, ...